Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 2Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms 2Melanoma 2Lymphedema 2Hematologic Neoplasms 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Tongue Neoplasms 1Testicular Neoplasms 1Teratoma 1Smoking Cessation 1Smoking 1Sexual Dysfunction, Physiological 1Polyps 1Peritoneal Neoplasms 1Paraganglioma, Extra-Adrenal 1Pain 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Oligodendroglioma 1Neuroblastoma 1Neoplasms, Plasma Cell 1Mouth Neoplasms 1Medulloblastoma 1

Interventions

Endoscopy 2Eicosapentaenoic Acid 2pegvisomant 1Restraint, Physical 1Microspheres 1Colonoscopy 1Clinical Chemistry Tests 1Cholecalciferol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hyperplasia × Restraint, Physical × Clear all
NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡